In conclusion, allergen signatures derived from clinical IgE panels elucidate the symptom heterogeneity captured by the SNOT-22 in CRS, and incorporating these signatures into routine assessments may support personalized, domain-focused management. The gene discussed is IGHE; the disease is congenital rubella syndrome.